BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20396853)

  • 41. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the COVID-19 Pandemic on Cervical Cancer Screening in São Paulo State, Brazil.
    Martins TR; Witkin SS; Mendes-Corrêa MC; Godoy AS; Cury L; Balancin ML; Ab'Saber AM; Peres SV; Messias S; Tozetto Mendoza TR; Longatto-Filho A
    Acta Cytol; 2023; 67(4):388-394. PubMed ID: 36682351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge, attitude and practice of the pap smear as a screening procedure among nurses in a tertiary hospital in north eastern India.
    Thippeveeranna C; Mohan SS; Singh LR; Singh NN
    Asian Pac J Cancer Prev; 2013; 14(2):849-52. PubMed ID: 23621250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010.
    Joseph R; Manosoontorn S; Petcharoen N; Sangrajrang S; Senkomago V; Saraiya M
    J Womens Health (Larchmt); 2015 Dec; 24(12):966-8. PubMed ID: 26653868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.
    Benard VB; Howe W; Royalty J; Helsel W; Kammerer W; Richardson LC
    J Womens Health (Larchmt); 2012 Jul; 21(7):776-82. PubMed ID: 22506920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervical cancer screening after 50: near extinction?
    Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mortality trends from uterine cervical cancer in the city of São Paulo from 1980 to 1999].
    Fonseca LA; Ramacciotti Ade S; Eluf Neto J
    Cad Saude Publica; 2004; 20(1):136-42. PubMed ID: 15029314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
    Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
    Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014.
    Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM
    Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excessive Pap smears due to opportunistic cervical cancer screening.
    Freitas RA; Carvasan GA; Morais SS; Zeferino LC
    Eur J Gynaecol Oncol; 2008; 29(5):479-82. PubMed ID: 19051817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in cervical cancer and its precursor forms to evaluate screening policies in a mid-sized Northeastern Brazilian city.
    Lima MS; Brito ÉAC; Siqueira HFF; Santos MO; da Silva AM; Nunes MAP; Brito HLF; Lima MMM; Cipolotti R; Lima CA
    PLoS One; 2020; 15(5):e0233354. PubMed ID: 32428033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quality and performance of pap smears in the cervical cancer screening program in a city of southern Brazil].
    Uchimura NS; Nakano K; Nakano LC; Uchimura TT
    Rev Assoc Med Bras (1992); 2009; 55(5):569-74. PubMed ID: 19918658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Randomized Controlled Trial of a Cervical Cancer Education Intervention for Latinas Delivered Through Interactive, Multimedia Kiosks.
    Valdez A; Napoles AM; Stewart SL; Garza A
    J Cancer Educ; 2018 Feb; 33(1):222-230. PubMed ID: 27573420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 56. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical cancer screening among vulnerable women: factors affecting guideline adherence at a community health centre in Toronto, Ont.
    Wiedmeyer ML; Lofters A; Rashid M
    Can Fam Physician; 2012 Sep; 58(9):e521-6. PubMed ID: 22972744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
    Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
    Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The paradigm shift in cervical cancer screening in Germany.
    Hillemanns P
    Arch Gynecol Obstet; 2016 Jan; 293(1):3-4. PubMed ID: 26514679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with the achievement of cervical smears by general practitioners.
    Rochoy M; Raginel T; Favre J; Soueres E; Messaadi N; Deken V; Duhamel A; Berkhout C
    BMC Res Notes; 2017 Dec; 10(1):723. PubMed ID: 29221494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.